Hemorrhoid is a common disease in a general population, which is also known as the piles, where the patient suffers from painless bleeding during bowel movement, itching and irritation in anal side, swelling of anal veins, pain and discomfort, and formation of lumps near to anus, which is sensitive and painful. Hemorrhoid is distinguished into two parts such as internal hemorrhoid and external hemorrhoid.
Treatment for hemorrhoid disease includes non-surgical treatment and surgical treatment. Non-surgical treatment includes laxatives and corticosteroids. Surgical treatment includes banding, sclerotherapy, infrared coagulation, hemorrhoidectomy, and hemorrhoid sampling. Various devices are used for the treatment of hemorrhoid such as endoscopic rubber band ligator, hemorrhoidal multi-band ligator, disposable hemorrhoid banding system, mcgivney hemorrhoidal ligator, endoscopic infrared coagulator, and lumatec infrared coagulator.
Global Hemorrhoid Treatment Devices Market Drivers
New product launches is expected to drive the global hemorrhoid treatment devices market size. For instance, in March 2019, De Scalene launched a new device called Cryocure, an affordable device to treat hemorrhoid without surgery. Cryocure helps to stop the bleeding from anal blood vessels and constriction of that anal blood vessels.
Furthermore, increasing incidence and prevalence of hemorrhoid disease in the U.S. is expected to drive the global hemorrhoid treatment devices market growth. For instance, in March 2016, according to the National Center for Biotechnology Information (NCBI), overall prevalence of hemorrhoid disease in the general population is around 4.4% and self-reported incidence of hemorrhoid disease is around 10 million persons, annually in the U.S.
Global Hemorrhoid Treatment Devices Market Restraints
Product recall is the major challenge, which is expected to hamper the global hemorrhoid treatment device market forecast. For Instance, in September 2016, the U.S. Food and Drug Administration (FDA) recalled the product of Ultroid Technologies for the Hemorrhoid Management System (UHMS) device kits, procedure packs, including the Ultroid disposable sterile probes, as these devices had not been designed and manufactured according to the quality assurance procedures.
Global Hemorrhoid Treatment Devices Market Regional Analysis
North America is expected to hold dominant position in the global the hemorrhoid treatment device market, owing to increasing clearance for new hemorrhoid treatment devices from the U.S. FDA. For instance, in January 2018, PRIVI MEDICAL PTE. LTD., received U.S. FDA clearance for its new device (Instalief), which is used for the hemorrhoid treatment. Instalief is the drug-free device, which provides the instant cold relief without any side-effects.
Furthermore, Asia Pacific is also projected to witness significant growth in the global hemorrhoid treatment device market, owing to presence key manufacturers and vendors of hemorrhoid treatment devices in the Asia Pacific region. Majority of market players in the global hemorrhoid treatment devices market such as Zhengzhou Safute Electronic Equipment Co., Ltd., and Wuxi Shenkang Medical Instrument Equipment Co. Ltd belong to China. These companies include various hemorrhoid treatment devices such as anorectal physical therapy device, SAFUTE hemorrhoid surgery device, and sigmoid colon and hemorrhoid disease treating device.
Key players operating in the global hemorrhoid treatment device market include Johnson & Johnson, PRIVI MEDICAL PTE. LTD., Cook Medical, Medtronic Plc, Integra LifeSciences Corporation, OBP Medical Corporation, Boston Scientific Corporation, Sklar Surgical Instruments, Surkon Medical Co., Ltd., and CONMED Corporation.
Global Hemorrhoid Treatment Devices Market Taxonomy
By Product Type:
- Rubber Band Ligators
- Sclerotherapy Injections
- Cryotherapy Devices
- Infrared Coagulators
- Laser Probes
- Bipolar Probes
- Hospitals and Clinics
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- Latin America
- Middle East